|
Delayed
Japan Exchange
22:30:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 1,093.00 JPY | +0.78% |
|
+6.01% | -34.02% |
| 10-07 | PeptiDream Secures Milestone Payment Under MSD Collaboration | MT |
| 08-12 | PeptiDream Hits Milestone as Novartis Begins Phase 1 Trial for Cancer Therapy | MT |
| Market Cap | 139B 882M 786M 728M 659M 1.24B 83.24B 1.26B 8.73B 3.42B 43.76B 3.31B 3.24B | P/E 2026 * |
20.7x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 126B 799M 712M 659M 596M 1.12B 75.38B 1.14B 7.9B 3.1B 39.62B 3B 2.93B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 2.92x |
| Free-Float |
72.25% | Yield 2026 * |
-
| Yield 2027 * | 0.37% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4587 | Delayed | |
OTC Markets
| PPTDF | Delayed |
Last Transcript: PeptiDream Inc.
| 1 day | +0.78% | ||
| 1 week | +6.01% | ||
| Current month | -1.84% | ||
| 1 month | +3.45% | ||
| 3 months | +14.52% | ||
| 6 months | -4.21% | ||
| Current year | -34.02% |
| 1 week | 1,031.5 |  | 1,111 |
| 1 month | 1,022.5 | | 1,144 |
| Current year | 906.4 | | 1,788 |
| 1 year | 906.4 | | 1,793 |
| 3 years | 906.4 | | 3,060 |
| 5 years | 906.4 | | 3,060 |
| 10 years | 906.4 | | 6,540 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Reid
CEO | Chief Executive Officer | 51 | 2021-12-31 |
Catherine Ohura
COO | Chief Operating Officer | - | 2026-07-01 |
| Chief Tech/Sci/R&D Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Reid
BRD | Director/Board Member | 51 | 2008-07-31 |
| Director/Board Member | 51 | 2017-08-31 | |
Junko Morita
BRD | Director/Board Member | 55 | 2021-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.78% | +6.01% | -34.94% | -13.39% | 848M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.34B | |
| +0.82% | +5.41% | +8.05% | +73.53% | 54.82B | |
| -0.22% | +6.53% | +11.68% | +87.32% | 52.92B | |
| +3.28% | +5.58% | +26.51% | +50.05% | 44.09B | |
| +0.51% | +9.95% | +22.40% | +133.92% | 43.72B | |
| -1.15% | +0.39% | +263.21% | +594.60% | 42.13B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 33.96B | |
| -5.22% | -3.78% | +30.65% | +1.41% | 26.17B | |
| +0.69% | +5.60% | +36.60% | +26.94% | 23.37B | |
| Average | -0.07% | +3.92% | +42.47% | +108.78% | 38.83B | |
| Weighted average by Cap. | +0.05% | +4.53% | +50.00% | +127.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.04B 228M 203M 188M 170M 321M 21.52B 325M 2.26B 885M 11.31B 855M 838M | 41.41B 262M 233M 216M 196M 369M 24.72B 373M 2.59B 1.02B 13B 983M 962M |
| Net income | 6.77B 42.81M 38.14M 35.32M 31.96M 60.21M 4.04B 60.93M 423M 166M 2.12B 161M 157M | 9.39B 59.38M 52.92M 48.99M 44.34M 83.53M 5.6B 84.52M 587M 230M 2.95B 223M 218M |
| Net Debt | -13.16B -83.29M -74.22M -68.71M -62.18M -117M -7.86B -119M -824M -323M -4.13B -312M -306M | -18.42B -117M -104M -96.14M -87.01M -164M -11B -166M -1.15B -452M -5.78B -437M -428M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | JP¥1,093.00 | +0.78% | 273,600 |
| 26-10-21 | JP¥1,084.50 | +3.93% | 1,136,300 |
| 26-10-20 | JP¥1,043.50 | -0.52% | 532,000 |
| 26-10-19 | JP¥1,049.00 | -2.19% | 707,200 |
| 26-10-16 | JP¥1,072.50 | +4.03% | 555,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4587 Stock
Select your edition
All financial news and data tailored to specific country editions
